ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Clinical trials for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION trials appear
Sign up with your email to follow new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for stubborn low platelets after transplant?
Disease control Not yet recruitingThis study tests the drug baricitinib in 28 adults who have dangerously low platelet counts after a stem cell transplant and did not improve with standard treatments. The goal is to see if baricitinib can safely raise platelet levels enough to reduce the need for transfusions. Th…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: PHASE1, PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 15, 2026 19:06 UTC
-
New study aims to predict heart trouble in stem cell recipients
Knowledge-focused Not yet recruitingThis study will follow 400 people receiving a stem cell transplant to learn why some develop serious heart issues like heart attacks, irregular heartbeat, or heart failure. Researchers will use heart scans, blood tests, and other monitoring to find early warning signs. The goal i…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:56 UTC
-
Stem cell patients monitored for superbug threat
Knowledge-focused Not yet recruitingThis study follows 1000 adult stem cell transplant patients to track a type of drug-resistant bacteria (MBL-CRE) that can cause serious infections. Researchers will swab the perianal area regularly to see how often patients carry these bacteria and how many later get sick from th…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:13 UTC